Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation
The effects of the same form of crystalline silica variously modified were compared to investigate the mechanisms by which silica activates C5 molecules. After incubation in human plasma, silica generated C5a-type fragments that stimulated polymorphonuclear leukocyte chemotaxis. This activity was to...
Gespeichert in:
Veröffentlicht in: | Toxicology and applied pharmacology 2002-03, Vol.179 (3), p.129-136 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 136 |
---|---|
container_issue | 3 |
container_start_page | 129 |
container_title | Toxicology and applied pharmacology |
container_volume | 179 |
creator | Governa, Mario Fenoglio, Ivana Amati, Monica Valentino, Matteo Bolognini, Lucia Coloccini, Sabrina Volpe, Anna Rita Carmignani, Marco Fubini, Bice |
description | The effects of the same form of crystalline silica variously modified were compared to investigate the mechanisms by which silica activates C5 molecules. After incubation in human plasma, silica generated C5a-type fragments that stimulated polymorphonuclear leukocyte chemotaxis. This activity was totally abolished when plasma, adsorbed with antiserum against C5a or thermally inactivated, was used. Pretreatment of plasma with deferoxamine, 1,3 dimethyl-2-thiourea, or aprotinin markedly inhibited or totally abolished C5 activation. Finally, a significant increase in kallikrein activity was detected after incubation of silica particles in plasma. The results seem to indicate that the activation of C5 by crystalline silica occurs through a complex mechanism: the redox-active iron possibly present at the silica surface catalyzes, via Haber–Weiss cycles, the production of hydroxyl radicals, which in turn convert native C5 to an oxidized C5-like form. This product is then cleaved by kallikrein, activated by the same silica particles, yielding oxidized C5a with the same functional properties as C5a. The different types of the same form of silica exhibited different reactivity. Two separate properties of the dusts seem to contribute to C5 activation: the potential to release hydroxyl radicals and the extent of C5 adsorption at the surface. The degree of surface hydrophobicity/hydrophilicity appeared sufficient to explain the different responses. |
doi_str_mv | 10.1006/taap.2002.9351 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18309053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X02993518</els_id><sourcerecordid>18309053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-47fa4edcfc4fe456cb2ec5d64b0c4f2fb6815153e425b400605668883c80106e3</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS0EokvhyhH5Arcs49gxybGKum3VSqAWJG6R40y6po4TbGfR_jT-Hc7uSj1xsvT8vTejeYS8Z7BmAPJzVGpa5wD5uuIFe0FWDCqZAef8JVkBCJYBlD_PyJsQfgFAJQR7Tc4Yq0DmIl-Rv7VFtVOPSMeexi3SjenjltbjMI0OXVzk63lQ7iBZHBZNuY7eYzKGg03Rh8maSL_5sZt1pH_MklCozJonpBc6mp2Je9ruae33ISprjUP6YKzRKs304_y4pRuPSO9VlzRLr9ChV9GM7jDrdrE8eTTumHb4eUte9coGfHd6z8mPzeX3-jq7-3p1U1_cZVoAi5n40iuBne616FEUUrc56qKTooWk5H0rS1awgqPIi1akk0IhZVmWXJfAQCI_J5-OuZMff88YYjOYoNFa5XCcQ8NKDhUUPIHrI6j9GILHvpm8GZTfNwyapaxmKatZymqWspLhwyl5bgfsnvFTOwn4eAJUSGfpvXLahGeOS1ZJJhNXHjlMd9gZ9E3QBp3GznjUselG878d_gGrjrJu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18309053</pqid></control><display><type>article</type><title>Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Governa, Mario ; Fenoglio, Ivana ; Amati, Monica ; Valentino, Matteo ; Bolognini, Lucia ; Coloccini, Sabrina ; Volpe, Anna Rita ; Carmignani, Marco ; Fubini, Bice</creator><creatorcontrib>Governa, Mario ; Fenoglio, Ivana ; Amati, Monica ; Valentino, Matteo ; Bolognini, Lucia ; Coloccini, Sabrina ; Volpe, Anna Rita ; Carmignani, Marco ; Fubini, Bice</creatorcontrib><description>The effects of the same form of crystalline silica variously modified were compared to investigate the mechanisms by which silica activates C5 molecules. After incubation in human plasma, silica generated C5a-type fragments that stimulated polymorphonuclear leukocyte chemotaxis. This activity was totally abolished when plasma, adsorbed with antiserum against C5a or thermally inactivated, was used. Pretreatment of plasma with deferoxamine, 1,3 dimethyl-2-thiourea, or aprotinin markedly inhibited or totally abolished C5 activation. Finally, a significant increase in kallikrein activity was detected after incubation of silica particles in plasma. The results seem to indicate that the activation of C5 by crystalline silica occurs through a complex mechanism: the redox-active iron possibly present at the silica surface catalyzes, via Haber–Weiss cycles, the production of hydroxyl radicals, which in turn convert native C5 to an oxidized C5-like form. This product is then cleaved by kallikrein, activated by the same silica particles, yielding oxidized C5a with the same functional properties as C5a. The different types of the same form of silica exhibited different reactivity. Two separate properties of the dusts seem to contribute to C5 activation: the potential to release hydroxyl radicals and the extent of C5 adsorption at the surface. The degree of surface hydrophobicity/hydrophilicity appeared sufficient to explain the different responses.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1006/taap.2002.9351</identifier><identifier>PMID: 11906242</identifier><identifier>CODEN: TXAPA9</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; C5 activation ; Chemical and industrial products toxicology. Toxic occupational diseases ; Chemotaxis - drug effects ; complement ; Complement Activation - drug effects ; Complement C5 - antagonists & inhibitors ; Complement C5 - metabolism ; Complement C5a - metabolism ; crystalline silica ; Deferoxamine - pharmacology ; Female ; Free Radical Scavengers - pharmacology ; Humans ; Hydroxyl Radical - metabolism ; Inorganic dusts (pneumoconiosises) and organic dusts (byssinosis etc.) ; Iron - pharmacology ; Iron Chelating Agents - pharmacology ; kallikrein ; Kallikreins - blood ; Male ; Medical sciences ; Middle Aged ; Neutrophils - drug effects ; Quartz - pharmacology ; Quartz - toxicity ; silicon dioxide ; Thiourea - analogs & derivatives ; Thiourea - pharmacology ; Toxicology ; Zymosan - pharmacology</subject><ispartof>Toxicology and applied pharmacology, 2002-03, Vol.179 (3), p.129-136</ispartof><rights>2002 Elsevier Science (USA)</rights><rights>2002 INIST-CNRS</rights><rights>Copyright 2002 Elsevier Science (USA).</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-47fa4edcfc4fe456cb2ec5d64b0c4f2fb6815153e425b400605668883c80106e3</citedby><cites>FETCH-LOGICAL-c401t-47fa4edcfc4fe456cb2ec5d64b0c4f2fb6815153e425b400605668883c80106e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041008X02993518$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13619616$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11906242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Governa, Mario</creatorcontrib><creatorcontrib>Fenoglio, Ivana</creatorcontrib><creatorcontrib>Amati, Monica</creatorcontrib><creatorcontrib>Valentino, Matteo</creatorcontrib><creatorcontrib>Bolognini, Lucia</creatorcontrib><creatorcontrib>Coloccini, Sabrina</creatorcontrib><creatorcontrib>Volpe, Anna Rita</creatorcontrib><creatorcontrib>Carmignani, Marco</creatorcontrib><creatorcontrib>Fubini, Bice</creatorcontrib><title>Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>The effects of the same form of crystalline silica variously modified were compared to investigate the mechanisms by which silica activates C5 molecules. After incubation in human plasma, silica generated C5a-type fragments that stimulated polymorphonuclear leukocyte chemotaxis. This activity was totally abolished when plasma, adsorbed with antiserum against C5a or thermally inactivated, was used. Pretreatment of plasma with deferoxamine, 1,3 dimethyl-2-thiourea, or aprotinin markedly inhibited or totally abolished C5 activation. Finally, a significant increase in kallikrein activity was detected after incubation of silica particles in plasma. The results seem to indicate that the activation of C5 by crystalline silica occurs through a complex mechanism: the redox-active iron possibly present at the silica surface catalyzes, via Haber–Weiss cycles, the production of hydroxyl radicals, which in turn convert native C5 to an oxidized C5-like form. This product is then cleaved by kallikrein, activated by the same silica particles, yielding oxidized C5a with the same functional properties as C5a. The different types of the same form of silica exhibited different reactivity. Two separate properties of the dusts seem to contribute to C5 activation: the potential to release hydroxyl radicals and the extent of C5 adsorption at the surface. The degree of surface hydrophobicity/hydrophilicity appeared sufficient to explain the different responses.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>C5 activation</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Chemotaxis - drug effects</subject><subject>complement</subject><subject>Complement Activation - drug effects</subject><subject>Complement C5 - antagonists & inhibitors</subject><subject>Complement C5 - metabolism</subject><subject>Complement C5a - metabolism</subject><subject>crystalline silica</subject><subject>Deferoxamine - pharmacology</subject><subject>Female</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Humans</subject><subject>Hydroxyl Radical - metabolism</subject><subject>Inorganic dusts (pneumoconiosises) and organic dusts (byssinosis etc.)</subject><subject>Iron - pharmacology</subject><subject>Iron Chelating Agents - pharmacology</subject><subject>kallikrein</subject><subject>Kallikreins - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neutrophils - drug effects</subject><subject>Quartz - pharmacology</subject><subject>Quartz - toxicity</subject><subject>silicon dioxide</subject><subject>Thiourea - analogs & derivatives</subject><subject>Thiourea - pharmacology</subject><subject>Toxicology</subject><subject>Zymosan - pharmacology</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUFv1DAQhS0EokvhyhH5Arcs49gxybGKum3VSqAWJG6R40y6po4TbGfR_jT-Hc7uSj1xsvT8vTejeYS8Z7BmAPJzVGpa5wD5uuIFe0FWDCqZAef8JVkBCJYBlD_PyJsQfgFAJQR7Tc4Yq0DmIl-Rv7VFtVOPSMeexi3SjenjltbjMI0OXVzk63lQ7iBZHBZNuY7eYzKGg03Rh8maSL_5sZt1pH_MklCozJonpBc6mp2Je9ruae33ISprjUP6YKzRKs304_y4pRuPSO9VlzRLr9ChV9GM7jDrdrE8eTTumHb4eUte9coGfHd6z8mPzeX3-jq7-3p1U1_cZVoAi5n40iuBne616FEUUrc56qKTooWk5H0rS1awgqPIi1akk0IhZVmWXJfAQCI_J5-OuZMff88YYjOYoNFa5XCcQ8NKDhUUPIHrI6j9GILHvpm8GZTfNwyapaxmKatZymqWspLhwyl5bgfsnvFTOwn4eAJUSGfpvXLahGeOS1ZJJhNXHjlMd9gZ9E3QBp3GznjUselG878d_gGrjrJu</recordid><startdate>20020315</startdate><enddate>20020315</enddate><creator>Governa, Mario</creator><creator>Fenoglio, Ivana</creator><creator>Amati, Monica</creator><creator>Valentino, Matteo</creator><creator>Bolognini, Lucia</creator><creator>Coloccini, Sabrina</creator><creator>Volpe, Anna Rita</creator><creator>Carmignani, Marco</creator><creator>Fubini, Bice</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20020315</creationdate><title>Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation</title><author>Governa, Mario ; Fenoglio, Ivana ; Amati, Monica ; Valentino, Matteo ; Bolognini, Lucia ; Coloccini, Sabrina ; Volpe, Anna Rita ; Carmignani, Marco ; Fubini, Bice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-47fa4edcfc4fe456cb2ec5d64b0c4f2fb6815153e425b400605668883c80106e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>C5 activation</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Chemotaxis - drug effects</topic><topic>complement</topic><topic>Complement Activation - drug effects</topic><topic>Complement C5 - antagonists & inhibitors</topic><topic>Complement C5 - metabolism</topic><topic>Complement C5a - metabolism</topic><topic>crystalline silica</topic><topic>Deferoxamine - pharmacology</topic><topic>Female</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Humans</topic><topic>Hydroxyl Radical - metabolism</topic><topic>Inorganic dusts (pneumoconiosises) and organic dusts (byssinosis etc.)</topic><topic>Iron - pharmacology</topic><topic>Iron Chelating Agents - pharmacology</topic><topic>kallikrein</topic><topic>Kallikreins - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neutrophils - drug effects</topic><topic>Quartz - pharmacology</topic><topic>Quartz - toxicity</topic><topic>silicon dioxide</topic><topic>Thiourea - analogs & derivatives</topic><topic>Thiourea - pharmacology</topic><topic>Toxicology</topic><topic>Zymosan - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Governa, Mario</creatorcontrib><creatorcontrib>Fenoglio, Ivana</creatorcontrib><creatorcontrib>Amati, Monica</creatorcontrib><creatorcontrib>Valentino, Matteo</creatorcontrib><creatorcontrib>Bolognini, Lucia</creatorcontrib><creatorcontrib>Coloccini, Sabrina</creatorcontrib><creatorcontrib>Volpe, Anna Rita</creatorcontrib><creatorcontrib>Carmignani, Marco</creatorcontrib><creatorcontrib>Fubini, Bice</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Governa, Mario</au><au>Fenoglio, Ivana</au><au>Amati, Monica</au><au>Valentino, Matteo</au><au>Bolognini, Lucia</au><au>Coloccini, Sabrina</au><au>Volpe, Anna Rita</au><au>Carmignani, Marco</au><au>Fubini, Bice</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2002-03-15</date><risdate>2002</risdate><volume>179</volume><issue>3</issue><spage>129</spage><epage>136</epage><pages>129-136</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><coden>TXAPA9</coden><abstract>The effects of the same form of crystalline silica variously modified were compared to investigate the mechanisms by which silica activates C5 molecules. After incubation in human plasma, silica generated C5a-type fragments that stimulated polymorphonuclear leukocyte chemotaxis. This activity was totally abolished when plasma, adsorbed with antiserum against C5a or thermally inactivated, was used. Pretreatment of plasma with deferoxamine, 1,3 dimethyl-2-thiourea, or aprotinin markedly inhibited or totally abolished C5 activation. Finally, a significant increase in kallikrein activity was detected after incubation of silica particles in plasma. The results seem to indicate that the activation of C5 by crystalline silica occurs through a complex mechanism: the redox-active iron possibly present at the silica surface catalyzes, via Haber–Weiss cycles, the production of hydroxyl radicals, which in turn convert native C5 to an oxidized C5-like form. This product is then cleaved by kallikrein, activated by the same silica particles, yielding oxidized C5a with the same functional properties as C5a. The different types of the same form of silica exhibited different reactivity. Two separate properties of the dusts seem to contribute to C5 activation: the potential to release hydroxyl radicals and the extent of C5 adsorption at the surface. The degree of surface hydrophobicity/hydrophilicity appeared sufficient to explain the different responses.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>11906242</pmid><doi>10.1006/taap.2002.9351</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-008X |
ispartof | Toxicology and applied pharmacology, 2002-03, Vol.179 (3), p.129-136 |
issn | 0041-008X 1096-0333 |
language | eng |
recordid | cdi_proquest_miscellaneous_18309053 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Biological and medical sciences C5 activation Chemical and industrial products toxicology. Toxic occupational diseases Chemotaxis - drug effects complement Complement Activation - drug effects Complement C5 - antagonists & inhibitors Complement C5 - metabolism Complement C5a - metabolism crystalline silica Deferoxamine - pharmacology Female Free Radical Scavengers - pharmacology Humans Hydroxyl Radical - metabolism Inorganic dusts (pneumoconiosises) and organic dusts (byssinosis etc.) Iron - pharmacology Iron Chelating Agents - pharmacology kallikrein Kallikreins - blood Male Medical sciences Middle Aged Neutrophils - drug effects Quartz - pharmacology Quartz - toxicity silicon dioxide Thiourea - analogs & derivatives Thiourea - pharmacology Toxicology Zymosan - pharmacology |
title | Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A54%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cleavage%20of%20the%20Fifth%20Component%20of%20Human%20Complement%20and%20Release%20of%20a%20Split%20Product%20with%20C5a-like%20Activity%20by%20Crystalline%20Silica%20through%20Free%20Radical%20Generation%20and%20Kallikrein%20Activation&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Governa,%20Mario&rft.date=2002-03-15&rft.volume=179&rft.issue=3&rft.spage=129&rft.epage=136&rft.pages=129-136&rft.issn=0041-008X&rft.eissn=1096-0333&rft.coden=TXAPA9&rft_id=info:doi/10.1006/taap.2002.9351&rft_dat=%3Cproquest_cross%3E18309053%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18309053&rft_id=info:pmid/11906242&rft_els_id=S0041008X02993518&rfr_iscdi=true |